CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nervi, C.
Right arrow Articles by Adamo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nervi, C.
Right arrow Articles by Adamo, S.

Cell Growth & Differentiation, Vol 6, Issue 1 81-89, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Arginine-vasopressin induces differentiation of skeletal myogenic cells and up-regulation of myogenin and Myf-5

C Nervi, L Benedetti, A Minasi, M Molinaro and S Adamo
Institute of Histology and General Embryology, University of Rome La Sapienza, Italy.

The neurohypophyseal nonapeptide arginine8-vasopressin (AVP) induces phosphoinositide turnover and calcium and pH changes in skeletal myogenic cells in culture. In order to investigate the effect of AVP on skeletal myogenesis, we examined the effect of this hormone on proliferating mononucleated L6 myoblast cultures. Addition of AVP to the medium resulted in the formation of much larger myotubes than those formed in its absence and in a significant increase (2.2-fold) of the percentage of fusion within 3-4 days of treatment. The effect of AVP was dose dependent, in the 10 nM to 1 microM range, and was observed also in primary cultures of mouse satellite cells. The rate of growth of L6 cells was not affected by AVP treatment. The induction of morphological differentiation by AVP correlated with an increased expression of muscle-specific gene products, such as myosin, and an increased number of acetylcholine receptor sites. The accumulation of mRNA transcripts of the acetylcholine receptor subunits was also enhanced by AVP. The mechanism involved in the myogenic action of AVP was investigated. Using AVP-related peptides and antagonists, we found that a specific chemical structure is required and that V1 receptors probably mediate the effect on myogenesis. Expression of muscle-specific transcription factor genes Myf-5 and myogenin and their products are strongly upregulated by AVP. Our findings support the hypothesis that AVP may represent a novel physiological modulator of skeletal muscle differentiation through its action on muscle regulatory genes.


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
N. De Jager, N. J. Hudson, A. Reverter, Y.-H. Wang, S. H. Nagaraj, L. M. Cafe, P. L. Greenwood, R. T. Barnard, K. P. Kongsuwan, and B. P. Dalrymple
Chronic exposure to anabolic steroids induces the muscle expression of oxytocin and a more than fiftyfold increase in circulating oxytocin in cattle
Physiol Genomics, May 13, 2011; 43(9): 467 - 478.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Gassanov, M. Jankowski, B. Danalache, D. Wang, R. Grygorczyk, U. C. Hoppe, and J. Gutkowska
Arginine Vasopressin-mediated Cardiac Differentiation: INSIGHTS INTO THE ROLE OF ITS RECEPTORS AND NITRIC OXIDE SIGNALING
J. Biol. Chem., April 13, 2007; 282(15): 11255 - 11265.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Mebarek, H. Komati, F. Naro, C. Zeiller, M. Alvisi, M. Lagarde, A.-F. Prigent, and G. Nemoz
Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation
J. Cell Sci., February 1, 2007; 120(3): 407 - 416.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B. M. Scicchitano, L. Spath, A. Musaro, M. Molinaro, N. Rosenthal, C. Nervi, and S. Adamo
Vasopressin-dependent Myogenic Cell Differentiation Is Mediated by Both Ca2+/Calmodulin-dependent Kinase and Calcineurin Pathways
Mol. Biol. Cell, August 1, 2005; 16(8): 3632 - 3641.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Komati, F. Naro, S. Mebarek, V. De Arcangelis, S. Adamo, M. Lagarde, A.-F. Prigent, and G. Nemoz
Phospholipase D Is Involved in Myogenic Differentiation through Remodeling of Actin Cytoskeleton
Mol. Biol. Cell, March 1, 2005; 16(3): 1232 - 1244.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
F. Naro, V. De Arcangelis, C. Sette, C. Ambrosio, H. Komati, M. Molinaro, S. Adamo, and G. Nemoz
A Bimodal Modulation of the cAMP Pathway Is Involved in the Control of Myogenic Differentiation in L6 Cells
J. Biol. Chem., December 5, 2003; 278(49): 49308 - 49315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Naro, V. De Arcangelis, D. Coletti, M. Molinaro, B. Zani, S. Vassanelli, C. Reggiani, A. Teti, and S. Adamo
Increase in cytosolic Ca2+ induced by elevation of extracellular Ca2+ in skeletal myogenic cells
Am J Physiol Cell Physiol, April 1, 2003; 284(4): C969 - C976.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
V. De Arcangelis, D. Coletti, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, G. Nemoz, and F. Naro
IGF-I-induced Differentiation of L6 Myogenic Cells Requires the Activity of cAMP-Phosphodiesterase
Mol. Biol. Cell, April 1, 2003; 14(4): 1392 - 1404.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. B. Friday and G. K. Pavlath
A calcineurin- and NFAT-dependent pathway regulates Myf5 gene expression in skeletal muscle reserve cells
J. Cell Sci., January 15, 2001; 114(2): 303 - 310.
[Abstract] [PDF]


Home page
Mol. Biol. CellHome page
F. Naro, C. Sette, E. Vicini, V. De Arcangelis, M. Grange, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, and G. Nemoz
Involvement of Type 4 cAMP-Phosphodiesterase in the Myogenic Differentiation of L6 Cells
Mol. Biol. Cell, December 1, 1999; 10(12): 4355 - 4367.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.